HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ca2+ entry following store depletion in SH-SY5Y neuroblastoma cells.

Abstract
Ca2+ entry following Ca2+ store depletion was examined in the human neuroblastoma cell line, SH-SY5Y, by measuring the concentration of intracellular free Ca2+ ([Ca2+]i) with fura-2. Application of the muscarinic agonist oxotremorine-M (oxo-M) caused an increase in [Ca2+]i. This consisted of a peak, mediated by release of Ca2+ from internal stores followed by a sustained plateau, mediated by Ca2+ entry across the plasma membrane. The Ca2+ entry resulted from depletion of intracellular Ca2+ stores This pathway was further characterized in the presence of thapsigargin, an inhibitor of the Ca2+ ATPase involved in replenishing IP3-sensitive stores. Stores were first depleted with oxo-M and thapsigargin in the absence of extracellular Ca2+. After washout of oxo-M, subsequent exposure to Ca2+ evoked reproducible increases in [Ca2+]i. Application of oxo-M plus Ca2+ had little effect on the increases in [Ca2+]i, indicating that in SH-SY5Y cells, agonist-dependent pathways contribute little to Ca2+ entry following store depletion. Mn2+, Sr2+ and Ba2+ were permeable through this pathway. Mn2+ and Ba2+ also showed slight permeability in the absence of store depletion. Ca2+ entry following store depletion was blocked by La3+ (IC50 = 75 nM) and by SKF 96365. La3+ blocked Mn2+ entry through the pathway activated by store depletion but did not affect basal Mn2+ permeability. These results indicate that SH-SY5Y neuroblastoma cells have an agonist-independent Ca2+ entry pathway activated by store depletion.
AuthorsT J Grudt, M M Usowicz, G Henderson
JournalBrain research. Molecular brain research (Brain Res Mol Brain Res) Vol. 36 Issue 1 Pg. 93-100 (Feb 1996) ISSN: 0169-328X [Print] Netherlands
PMID9011769 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Imidazoles
  • Muscarinic Agonists
  • Barium
  • Manganese
  • Oxotremorine
  • oxotremorine M
  • Thapsigargin
  • Lanthanum
  • Inositol 1,4,5-Trisphosphate
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole
  • Calcium
  • Strontium
Topics
  • Barium (pharmacokinetics)
  • Calcium (metabolism)
  • Cell Membrane Permeability
  • Imidazoles (pharmacology)
  • Inositol 1,4,5-Trisphosphate (metabolism)
  • Lanthanum (pharmacology)
  • Manganese (pharmacokinetics)
  • Muscarinic Agonists (pharmacology)
  • Neuroblastoma
  • Neurons (metabolism)
  • Oxotremorine (analogs & derivatives, pharmacology)
  • Strontium (pharmacokinetics)
  • Thapsigargin (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: